Protecting against Pneumococcal Disease: Critical Interactions between Probiotics and the Airway Microbiome

1. O'BrienKLWolfsonLJWattJPHenkleEDeloria-KnollM 2009 Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374 893 902

2. SaidMAO'BrienKLNuortiJPSingletonRWhitneyCG 2011 The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine 29 5355 5362

3. JacupsSPChengA 2011 The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia–over 22 years. Vaccine 29 5386 5392

4. MalleyR 2010 Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med (Berl) 88 135 142

5. IsaacmanDJStruttonDRKalpasEAHorowicz-MehlerNSternLS 2008 The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Clin Ther 30 341 357

6. JohnsonHLDeloria-KnollMLevineOSStoszekSKFreimanis HanceL 2010 Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 7: e1000348 doi:10.1371/journal.pmed.1000348

7. Lob-LevytJ 2011 Contribution of the GAVI Alliance to improving health and reducing poverty. Philos Trans R Soc Lond B Biol Sci 366 2743 2747

8. NossalGJ 2011 Vaccines and future global health needs. Philos Trans R Soc Lond B Biol Sci 366 2833 2840

9. O'GradyKAKrauseVAndrewsR 2009 Immunisation coverage in Australian Indigenous children: time to move the goal posts. Vaccine 27 307 312

10. MelegaroAChoiYHGeorgeREdmundsWJMillerE 2010 Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis 10 90

11. FerreiraRBAntunesLCFinlayBB 2010 Should the human microbiome be considered when developing vaccines? PLoS Pathog 6: e1001190 doi:10.1371/journal.ppat.1001190.

12. DaganRGivon-LaviNGreenbergDFritzellBSiegristCA 2010 Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis 201 1570 1579

13. RodenburgGDvan GilsEJVeenhovenRHBogaertDvan den DobbelsteenGP 2011 Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae. J Pediatr 159 965 970

14. GareauMGShermanPMWalkerWA 2010 Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7 503 514

15. BraeggerCChmielewskaADecsiTKolacekSMihatschW 2011 Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 52 238 250

16. BoyleRJRobins-BrowneRMTangML 2006 Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83 1256 1264; quiz 1446–1257

17. TangMLLahtinenSJBoyleRJ 2010 Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 22 626 634

18. BronPAvan BaarlenPKleerebezemM 2011 Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10 66 78

19. YanFPolkDB 2011 Probiotics and immune health. Curr Opin Gastroenterol 27 496 501

20. ReidGYounesJAVan der MeiHCGloorGBKnightR 2011 Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 9 27 38

21. MedinaMVillenaJSalvaSVintiniELangellaP 2008 Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiol Immunol 52 399 409

22. Cangemi de GutierrezRSantosVNader-MaciasME 2001 Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol Med Microbiol 31 187 195

23. RacedoSVillenaJMedinaMAgueroGRodriguezV 2006 Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect 8 2359 2366

24. GluckUGebbersJO 2003 Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77 517 520

25. NiessJHLeithauserFAdlerGReimannJ 2008 Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol 180 559 568

26. O'MahonyCScullyPO'MahonyDMurphySO'BrienF 2008 Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 4: e1000112 doi:10.1371/journal.ppat.1000112.

27. WallsTPowerDTaggJ 2003 Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52 829 833

28. SantagatiMScillatoMPatanèFAielloCStefaniS 2012 Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol 65 23 31

29. GuglielmettiSTavernitiVMinuzzoMArioliSStuknyteM 2010 Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl Environ Microbiol 76 3948 3958

30. CosseauCDevineDADullaghanEGardyJLChikatamarlaA 2008 The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 76 4163 4175

31. PowerDABurtonJPChilcottCNDawesPJTaggJR 2008 Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis 27 1261 1263

32. HatakkaKBlomgrenKPohjavuoriSKaijalainenTPoussaT 2007 Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study. Clin Nutr 26 314 321

33. ThomasDWGreerFR 2010 Probiotics and prebiotics in pediatrics. Pediatrics 126 1217 1231

34. KalliomakiMKirjavainenPEerolaEKeroPSalminenS 2001 Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107 129 134

35. WatanabeSNarisawaYAraseSOkamatsuHIkenagaT 2003 Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111 587 591

36. KalliomakiMSalminenSArvilommiHKeroPKoskinenP 2001 Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 1076 1079

37. LahtinenSJBoyleRJKivivuoriSOppedisanoFSmithKR 2009 Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol 123 499 501

38. SokolHPigneurBWatterlotLLakhdariOBermudez-HumaranLG 2008 Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105 16731 16736

39. IchinoheTPangIKKumamotoYPeaperDRHoJH 2011 Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A 108 5354 5359

40. MaslowskiKMVieiraATNgAKranichJSierroF 2009 Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 1282 1286

41. FukudaSTohHHaseKOshimaKNakanishiY 2011 Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 543 547

42. VintiniEVillenaJAlvarezSMedinaM 2010 Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice. Clin Exp Immunol 159 351 362

43. ElinavEStrowigTKauALHenao-MejiaJThaissCA 2011 NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 745 757

44. KukkonenKNieminenTPoussaTSavilahtiEKuitunenM 2006 Effect of probiotics on vaccine antibody responses in infancy–a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 17 416 421

45. MullieCYazourhAThibaultHOdouMFSingerE 2004 Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res 56 791 795

46. IsolauriEJoensuuJSuomalainenHLuomalaMVesikariT 1995 Improved immunogenicity of oral D×RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13 310 312

47. FangHElinaTHeikkiASeppoS 2000 Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 29 47 52

48. SohSEOngDQGerezIZhangXChollateP 2010 Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant hepatitis B vaccination. Vaccine 28 2577 2579

49. RemusDMKleerebezemMBronPA 2011 An intimate tête-à-tête - how probiotic lactobacilli communicate with the host. Eur J Pharmacol 668 S33 42

50. RescignoM 2011 The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol 32 256 264

51. WellsJM 2011 Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact 10 S17

52. MarcoMLPavanSKleerebezemM 2006 Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17 204 210